2025/1589 - IMUNOGLOBULINA HUMANA NORMAL, 165 MG/ML, SC (g)
TED · 391904-2026Award noticeawardedNo deadline given
Value
Estimated€145,946 · 145,945.8 EUR
Awarded—
WinnerOCTAPHARMA- PROD.FARMACEUTICOS, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
IMUNOGLOBULINA HUMANA NORMAL, 165 MG/ML, SC (g)
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-09 | 2025/1589 - IMUNOGLOBULINA HUMANA NORMAL, 165 MG/ML, SC (g) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-09 | 2025/1589 -MOMELOTINIB [200 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-08-04 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-05-12 | 2025/1589 - MARIBAVIR [200 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |